RPAY · Repay Holdings Corporation

The thesis

Repay Holdings is a payments company whose shares still trade below Forager Capital's rejected $5.25 all-cash proposal, and nothing scheduled forces the gap to close. The Q3 2026 report, expected in the second week of November, and the 7 December 2026 Investor Day settle whether the standalone business can support a higher price.

The shares closed at $4.42 on 28 October 2026 (adjusted daily closes), 15.0% below the 52-week high of $5.20. The three-month price change is 10.5%. The 14-day relative strength index (RSI, a 0–100 momentum gauge) is 69.2, near the level usually read as stretched.

The narrative is maturing: the story is well known, and the latest company item remains the 23 September 2026 Investor Day notice. A search of company releases and news on 29 October 2026 found no Forager amendment, no new company release and no announcement of the Q3 reporting date. The shares have risen from $4.19 on 15 October 2026 without a published catalyst.

Bullish and bearish views on Repay Holdings Corporation

The bull case on Repay Holdings Corporation (RPAY), in brief: A specific cash proposal sits on the record. The bear case: The board has rejected the valuation.

Bull case

• A specific cash proposal sits on the record. Forager, the largest holder at 11,106,548 shares or 12.4% of the class (Schedule 13D/A, 3 June 2026), put $5.25 per share in cash in writing after an initial $4.80 proposal confirmed on 17 April 2026. The board rejected the revised offer unanimously and called it non-binding, so it marks a valuation view and not a floor.
• Second-quarter results beat the consensus. Revenue was $100.705M, up 33% year on year, against a $96.456M consensus (Q2 results, 10 August 2026). Free cash flow was $27.4M, about 75% of adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) of $36.3M.
• The full-year outlook was reiterated. Management held fiscal 2026 revenue at $490–500M and adjusted EBITDA at $168.5–176M on 10 August 2026. KUBRA, which closed on 1 June 2026, is consolidated for the first full quarter in Q3.
• An Investor Day gives management a stage. The company will present its financial and strategic outlook with KUBRA leaders on 7 December 2026 (company release, 23 September 2026). The release states no targets.

Bear case

• The board has rejected the valuation. The rejection was unanimous, and the board added a seventh director, Zachary Sadek of Parthenon Capital Partners, under a cooperation agreement. Plurality voting meant the roughly 36–37% withhold vote at the 10 June 2026 annual meeting unseated no one.
• Organic growth is slow and leverage is high. Q2 organic revenue growth was about 6%, the net loss was $11.5M, and pro forma net leverage was 3.7 times (Q2 call, 10 August 2026). The $500M term loan led by Silver Point Capital is floating-rate.
• The partnerships carry no disclosed numbers. The Visa Platform Connect reseller agreement and the NxtEdge accounts-payable partnership (company releases, 19 August 2026 and 26 August 2026) came with no financial terms.
• No forcing event is scheduled. The company has announced no strategic-alternatives process, and the Forager proposal has no stated expiry. Forager has filed nothing visible since the board's rejection.

Price setup

The shares closed at $4.42 on 28 October 2026 with an RSI of 69.2 (adjusted daily closes). The reading was 69.6 on 15 October 2026 and 55.5 on 2 October 2026, so momentum has held near its high for two weeks. The 52-week high in the adjusted series is $5.20, and the $5.25 proposal price sits above it.

The range held since the 10 August 2026 Q2 report has a lower end near $3.45. The 21 August 2026 close of $4.01 and the 2 October 2026 close of $3.82 both sit inside that range, and the latest close is above both. A close back under $3.82 with no Forager filing or company release in between would show the October rise was not supported.

Crowding evidence is limited. The Q3 report is about 11 days away on the pattern of prior years, which puts event risk close to a stretched momentum reading. Sell-side coverage is thin at five analysts, with targets from $5.00 to $12.00, so one revision moves the consensus.

Catalysts, next 30 days

• ~9 November 2026 (est.): Q3 2026 results, the first full quarter with KUBRA. The company announced the Q3 2025 date on 27 October 2025 for a 10 November 2025 call, and the Q2 2026 notice came 14 days before its 10 August 2026 report. No Q3 2026 notice had appeared in searches by 29 October 2026.
• 7 December 2026: Investor Day in New York, 10:00 a.m. ET, just beyond the 30-day window. It matters because management may set out a standalone financial case.

What would change the view

The case breaks if Forager withdraws the $5.25 proposal in a Schedule 13D/A, moves to Schedule 13G or sells below 5%. It also breaks if the Q3 report cuts the fiscal 2026 revenue outlook below $490M, or shows organic growth still near Q2's 6% with net leverage flat or higher than 3.7 times.

On price, a weekly close below $3.45 would put the shares under the lower end of the range held since 10 August 2026. A Q3 report that confirms second-half growth and a lower leverage figure would strengthen the standalone case.

What it trades with

Repay trades on its own company and holder events more than on sector moves. The Forager proposal and the 13D filings drive the price, with small-cap payments names a secondary influence. Floating-rate debt of $500M makes the shares sensitive to short-term interest rates. No current theme neighbour carries this name, so cross-stock moves give little independent read.